Log In
BCIQ
Print this Print this
 

Oral recombinant parathyroid hormone (Oral PTH1-34)

  Manage Alerts
Collapse Summary General Information
Company B&C Biopharm
DescriptionOral recombinant parathyroid hormone (PTH I-34)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase I
Standard IndicationOsteoporosis
Indication DetailsTreat bone related diseases; Treat osteoporosis; Treat post menopausal osteoporosis
Regulatory Designation
PartnerNovartis AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today